This article is the latest in the Health Affairs Forefront featured topic Accountable Care for Population Health, featuring analysis and discussion of how to understand, design, support, and measure ...
Panelists discuss how biosimilar manufacturers offer both high-wholesale acquisition cost (WAC) and low-WAC product versions to navigate complex reimbursement landscapes, sharing their experiences ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback